V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210001106 | 210001106 | null | null | null | 2016-01-02 | 2016-01-11 | EC | N | N | CARBOPLATIN + PACLITAXEL | 100956159 |
| 210001136 | 210001136 | null | null | null | 2018-05-02 | 2018-06-07 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100953189 |
| 210001139 | 210001139 | 1.67 | 106 | null | null | 2017-10-30 | null | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100383517 |
| 210001155 | 210001155 | null | null | null | null | 2017-11-04 | null | null | null | CARBOPLATIN + DOCETAXEL | 101362057 |
| 210001156 | 210001156 | null | null | null | null | 2018-10-15 | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 2 | N | CARBOPLATIN + DOCETAXEL | 100720681 |
| 210001169 | 210001169 | null | null | null | null | 2016-05-09 | EC | 02 | N | PACLITAXEL | 100871322 |
| 210001171 | 210001171 | null | null | null | 2018-09-21 | 2018-09-21 | Trastuzumab 21 day loading dose | N | N | EC | 100573648 |
| 210001186 | 210001186 | null | null | null | null | 2019-02-19 | FEC + DOCETAXEL | N | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101411236 |
| 210001191 | 210001191 | null | null | null | null | 2016-07-20 | FEC 100 | N | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101198830 |
| 210001240 | 210001240 | null | null | null | 2017-01-08 | 2017-01-08 | EC | 01 | N | TAC | 100693498 |
| 210001241 | 210001241 | null | null | null | 2017-11-29 | 2017-12-19 | Cisplatin + Pemetrexed | N | N | CARBOPLATIN + PACLITAXEL | 101819795 |
| 210001249 | 210001249 | null | null | null | null | 2019-10-28 | FEC 100 | null | null | CARBOPLATIN + DOCETAXEL | 101140414 |
| 210001260 | 210001260 | null | null | null | null | 2018-08-09 | FEC 100 | null | null | FEC + DOCETAXEL | 101390748 |
| 210001261 | 210001261 | 1.66 | 86.3 | null | null | 2017-02-27 | null | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100243160 |
| 210001285 | 210001285 | null | null | null | 2016-12-27 | 2017-01-16 | EC + PACLITAXEL | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 100361254 |
| 210001297 | 210001297 | null | null | null | null | 2017-09-06 | CYCLOPHOSPHAMIDE + EPIRUBICIN | null | null | EC | 100115428 |
| 210001298 | 210001298 | null | null | null | 2017-01-17 | 2017-02-09 | FEC + DOCETAXEL | 01 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100514619 |
| 210001301 | 210001301 | null | null | null | 2019-07-25 | 2019-07-30 | EC | N | N | FEC + DOCETAXEL | 101291089 |
| 210001324 | 210001324 | null | null | null | null | 2019-03-25 | FEC + DOCETAXEL | N | N | AC | 101359585 |
| 210001327 | 210001327 | 1.58 | 58.4 | null | null | 2018-12-15 | FEC + DOCETAXEL | null | N | CISPLATIN + PEMETREXED | 100407714 |
| 210001335 | 210001335 | 1.6 | 71.8 | null | 2017-11-19 | 2017-11-21 | FEC + DOCETAXEL | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100801182 |
| 210001348 | 210001348 | null | null | null | 2016-03-20 | 2016-04-04 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100956268 |
| 210001369 | 210001369 | 1.6 | 62.6 | null | null | 2018-05-18 | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101562370 |
| 210001396 | 210001396 | null | null | null | 2018-08-21 | 2018-08-25 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101230010 |
| 210001428 | 210001428 | null | null | null | null | 2019-09-10 | CARBOPLATIN + PACLITAXEL | null | null | AFATINIB | 100430680 |
| 210001467 | 210001467 | null | null | null | null | 2016-10-24 | null | 02 | N | BEVACIZUMAB | 100482303 |
| 210001482 | 210001482 | null | null | null | null | 2018-03-19 | PACLITAXEL | null | null | FEC + DOCETAXEL | 100612375 |
| 210001491 | 210001491 | null | null | null | null | 2017-01-16 | Docetaxel | null | null | EC | 101774199 |
| 210001526 | 210001526 | 1.75 | 76.9 | null | 2016-09-05 | 2016-09-08 | Letrozole + Palbociclib | N | N | ROSCO TRIAL | 100437991 |
| 210001574 | 210001574 | null | null | null | 2018-08-28 | 2018-08-28 | FEC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100513357 |
| 210001587 | 210001587 | null | null | null | 2016-07-14 | 2016-07-28 | null | 02 | N | FEC | 100415403 |
| 210001599 | 210001599 | null | null | null | null | 2016-07-30 | Capecitabine | null | null | PACLITAXEL | 101372051 |
| 210001609 | 210001609 | null | null | null | null | 2018-08-21 | FEC + DOCETAXEL | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100694121 |
| 210001615 | 210001615 | 1.56 | 65.6 | null | null | 2018-09-07 | Palbociclib | null | N | CARBOPLATIN + PACLITAXEL | 100676279 |
| 210001640 | 210001640 | null | null | null | null | 2019-01-25 | DOCETAXEL + TRASTUZUMAB | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101143276 |
| 210001650 | 210001650 | null | null | null | 2016-04-06 | 2016-04-07 | TCH (21 day Trastuzumab) Maint | 02 | null | FEC + DOCETAXEL | 101571088 |
| 210001662 | 210001662 | null | null | null | null | 2017-12-21 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL + TRASTUZUMAB | 101313815 |
| 210001668 | 210001668 | null | null | null | 2019-09-17 | 2019-09-19 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100455361 |
| 210001671 | 210001671 | null | null | null | null | 2018-12-04 | FEC + DOCETAXEL | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101033976 |
| 210001674 | 210001674 | null | null | null | 2019-10-05 | 2019-10-08 | Irinotecan + Modified De Gramont | 02 | N | TAC | 101836718 |
| 210001687 | 210001687 | 1.7 | null | null | 2019-02-22 | 2019-02-22 | Letrozole + Palbociclib | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100600249 |
| 210001717 | 210001717 | null | null | null | null | 2016-11-11 | FEC | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100807279 |
| 210001720 | 210001720 | null | null | Neo-adjuvant (N) | 2019-11-02 | 2019-11-03 | EC | 02 | N | PACLITAXEL | 101856112 |
| 210001757 | 210001757 | null | null | null | null | 2016-03-18 | Fulvestrant + Palbociclib | null | null | CARBOPLATIN | 101187319 |
| 210001768 | 210001768 | 1.7 | 59.8 | null | null | 2018-09-11 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101263147 |
| 210001777 | 210001777 | null | null | null | 2018-01-28 | 2018-02-04 | EC | N | N | FEC + TRASTUZUMAB | 101840523 |
| 210001785 | 210001785 | null | null | null | 2019-11-12 | 2019-11-20 | Paclitaxel 7 day | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101062121 |
| 210001814 | 210001814 | null | null | null | null | 2017-09-06 | Carboplatin AUC 2 - 5 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101129981 |
| 210001821 | 210001821 | null | null | Curative (C) | 2018-07-20 | 2018-07-24 | null | N | null | DOCETAXEL | 101461300 |
| 210001827 | 210001827 | null | null | null | null | 2017-04-25 | ROSCO Trial | null | null | PALBOCICLIB | 100794095 |